The Board proposes the rule amendment to update the rule regarding examination requirements and passing scores.

 

DEPARTMENT OF HEALTH

Board of Pharmacy

RULE NO.:RULE TITLE:

64B16-26.200Examination Requirements

PURPOSE AND EFFECT: The Board proposes the rule amendment to update the rule regarding examination requirements and passing scores.

SUMMARY: The rule will be updated regarding examination requirements and passing scores.

SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:

The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board, based upon the expertise and experience of its members, determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.

Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

RULEMAKING AUTHORITY: 456.017, 465.005 FS.

LAW IMPLEMENTED: 456.017 FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Erica White, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254.

 

THE FULL TEXT OF THE PROPOSED RULE IS:

 

64B16-26.200 Examination Requirements; Current Competency; Passing Scores.

(1) The examination provided in Section 465.007, F.S., shall be as follows:

(a)(1) Part A – North American Pharmacist Licensure Examination (NAPLEX).

(b)(2) Part B – Multistate Pharmacy Jurisprudence Examination (MPJE) – Florida Version.

(2) Current Clinical Competency Examination.  The Board hereby establishes the Pharmacist Assessment for Remediation Evaluation (PARE) offered by the National Association of Boards of Pharmacy (NABP) as the Board’s examination to assess current clinical competency in the practice of pharmacy.  The minimum passing scaled score shall be seventy-five percent (75%).

(3) Passing Scores. The minimum passing scaled score for the NAPLEX shall be seventy-five percent (75%).  The minimum passing scaled score for the MPJE shall be seventy-five percent (75%).

Rulemaking Specific Authority 456.017(1), 465.005 FS. Law Implemented 456.017(1)(b), (6), 456.036(9), 465.007(1), 465.0075 FS. History–New 10-17-79, Amended 2-8-81, 6-22-82, 8-16-84, 4-30-85, Formerly 21S-12.01, Amended 5-6-86, Formerly 21S-12.001, Amended 1-10-93, Formerly 21S-26.200, 61F10-26.200, Amended 7-1-97, Formerly 59X-26.200, Amended 3-22-99, 1-11-05, __________________.

 

NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Pharmacy

NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Pharmacy

DATE PROPOSED RULE APPROVED BY AGENCY HEAD: December 14, 2016

DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: January 25, 2017